Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07658040 · ClinicalTrials.gov registry record
Clareon TruPlus vs Tecnis Eyhance IOLs in Cataract Patients
A clinical trial, sponsored by Gainesville Eye Associates.
- Not yet
- Registry status
- 70
- Enrollment target
NCT07658040: Clinical Trial study, sponsored by Gainesville Eye Associates.
NCT07658040 is a clinical trial that has not yet begun recruiting, run by Gainesville Eye Associates. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07658040 has not yet begun recruiting, sponsored by Gainesville Eye Associates.
- NOT YET RECRUITING
- Registry status
- 70 participants
- Enrollment target
Study Summary
This study is a prospective, randomized, two-arm, single-center, single-surgeon, double-masked (subject and assessor) comparative study. It involves bilateral implantation of intraocular lenses (IOLs), comparing Clareon TruPlus IOL and Tecnis Eyhance IOLs in normal cataract patients. The study will be conducted at one site and will include a pre-operative visit and a 3-month post-operative assessment.
Interventions
- DEVICE Clareon TruPlus
- DEVICE Tecnis Eyhance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-08-09 |
| Est. Completion | 2027-08-09 |
What is known before NCT07658040 opens enrollment
NCT07658040 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Clareon TruPlus is the first listed.
NCT07658040 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07658040 about?
NCT07658040 is a clinical study titled "Clareon TruPlus vs Tecnis Eyhance IOLs in Cataract Patients". This study is a prospective, randomized, two-arm, single-center, single-surgeon, double-masked (subject and assessor) comparative study. It involves bilateral implantation of intraocular lenses (IOLs), comparing Clareon TruPlus IOL and Tecnis Eyhance IOLs in normal cataract patients. The study will ...
What is the current status of trial NCT07658040?
This trial is currently not yet recruiting. The enrollment target is 70 participants. The study started on 2026-08-09. Estimated completion is 2027-08-09.
What interventions are being tested in trial NCT07658040?
The interventions under investigation include: Clareon TruPlus (DEVICE), Tecnis Eyhance (DEVICE).
Who is sponsoring clinical trial NCT07658040?
This trial is sponsored by Gainesville Eye Associates, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI